Category: Editors’ Pick

Fauci Predicts Further Covid-19 Vaccine Success As Moderna Prepares To Submit Early Findings

Fauci described the vaccines by Pfizer and Moderna as a “major step not only for Covid-19 but for the entire field of vaccinology.”

Study Confirms Existence Of ‘Long Covid,’ With 7 In 10 Patients Experiencing Debilitating Symptoms Weeks After Hospital Discharge

40% of patients still had abnormal chest X-rays weeks after discharge, the researchers found, with nearly 10% of these getting worse.

Texas Climbs Past 1 Million Covid-19 Cases, Becoming The First State To Do So

The U.S. has shattered its record for new infections on five out of the past seven days.

Long Lasting HIV Drugs Hold Lessons For Us All

The successful results from a clinical trial of a new, long-acting HIV prevention drug are not just a critical milestone for those working on HIV/AIDS, but also for researchers working on other deadly infectious diseases.

Trump Falsely Takes Credit For Pfizer Vaccine Success, Accuses FDA And Democrats Of Stalling News Until After Election

Trump’s Operation Warp Speed didn’t fund the Pfizer drug, though the government did agree to buy the vaccine when approved.

What You Need To Know About Pfizer’s Covid-19 Vaccine

Developed with Pfizer’s partner BioNTech, if all goes well this vaccine would be the first of its kind to receive FDA approval.

One In Five Covid-19 Patients Diagnosed With A Mental Illness Within Three Months Of Testing Positive, Study Finds

People with pre-existing psychiatric conditions were 65% more likely to be diagnosed with Covid-19, a finding one researcher described as “unexpected”.

20 Million Doses Of Pfizer’s Covid-19 Vaccine Headed To Spain In Early 2021

Early data from the vaccine’s clinical trial shows it could be 90% effective at preventing the disease.

Underinsured Transgender People Are Turning To Riskier Sources For Hormones

Study finds that nearly 170,000 people who are transgender access hormones from friends, online or other non-licensed sources, which poses health and safety risks.

Three Billionaires Behind Pfizer’s Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results

The announcement that the Pfizer-BioNTech vaccine could be up to 90% effective against the coronavirus led to a surge in BioNTech’s stock, adding billions to the net worths of its founder Uğur Şahin and its largest investors, Thomas and Andreas Struen…